Baden Karton Products | badenboard.com
Biomolecules | Free Full-Text | Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma | HTML
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells | Journal for ImmunoTherapy of Cancer
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction - ScienceDirect
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells | Journal for ImmunoTherapy of Cancer
Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody - ScienceDirect
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction - ScienceDirect
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy - ScienceDirect
Umka Color GD2 – Umka Cardboard Mill d.o.o.
STARCOLOR MIRABELL™ GD2
Monoclonal antibody therapies for high risk neuroblastoma | BTT
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma | Science Translational Medicine
Baden Karton Products | badenboard.com
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma | Nature Communications
Frontiers | Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Frontiers | CAR T Cell Therapy for Neuroblastoma
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma | Journal of Hematology & Oncology | Full Text
GD2 CAR T cells against human glioblastoma | npj Precision Oncology
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity | PLOS ONE
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication | Nature Medicine
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | Journal for ImmunoTherapy of Cancer
KAPAG collection – KAPAG Board + Paper
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction - ScienceDirect
FC FOODCART / GD2 / MM Frohnleiten GmbH - MM digital - Product Details
ASC amino acid transporter 2, defined by enzyme‐mediated activation of radical sources, enhances malignancy of GD2‐positive small‐cell lung cancer - Esaki - 2018 - Cancer Science - Wiley Online Library
